medicinal cannabis
‘There’s a fair degree of trial and error at the moment.’
Chronic non-cancer pain is the leading indication for special access to medicinal cannabis products, despite doctors being urged not to prescribe for this indication Medicinal cannabis applications for chronic pain …
World News Wrapup: 30 June 2022
Walgreens takes Boots off the market; the pharmaceutical impact of the US Supreme Court overturning Roe v Wade: Pharmacy to boost cheaper cannabis sales US: Pharmacy giant Walgreens has dropped …
Research Roundup
Debbie Rigby takes a look at the latest in research news Cannabis-Based Products for Chronic Pain A systematic review of 18 RCTs and 7 cohort studies has concluded that oral …
‘Dramatic increase’ in cannabis approvals in past two years
Medicinal cannabis has been prescribed for over 140 conditions since the beginning of the program, with anxiety a leading indication, new study finds Since Australia’s medicinal cannabis program began in …
Demand skyrockets for medicinal cannabis
There has been a massive jump in the number of patients receiving medicinal cannabis through community pharmacy Medicinal cannabis use in Australia has skyrocketed in the last 12 months, according …
Pharmacy handed $40k cannabis fine
A pharmacy has been fined nearly $40,000 over its advertising of medicinal cannabis including an in-store poster The Therapeutic Goods Administration has issued three infringement notices, totalling $39,960, to a …
Restricted representations
The TGA has handed down more than $23K in fines relating to unlawful advertising of medicinal cannabis to treat cancer, and of homeopathy for COVID-19 The Therapeutic Goods Administration made …
Research Roundup
Debbie Rigby takes a look at the latest in research news Integration of non-dispensing pharmacists into primary healthcare services This umbrella review and narrative synthesis suggest that the integration of …
Research Roundup
Debbie Rigby rounds up the latest in research news Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community Interim analyses from the PRINCIPLE trial …
Medicinal cannabis warning
With certain medicinal cannabis products now S3 but not yet available in pharmacy, the TGA is warning about the risks of buying online On Monday the Therapeutic Goods Administration warned …
Research Roundup
Debbie Rigby rounds up the latest in research news Multiple short courses of corticosteroids in children Short courses of oral steroids (less than two weeks) in children are very unlikely …
Clinical tips: Medical Cannabis
Ben Basger takes a look at some issues around medicinal cannabis, including the fact that data is still very much emerging Speaking to our Professor of Pain Management and Palliative …